Dr. Robert Malenka — Professor of Psychiatry and Behavioral Sciences at Stanford (MD and PhD) whose lab pioneered the neuroplasticity of reward circuitry. A field-shaping mentor whose trainees lead many top neuroscience labs.
The gist
Andrew Huberman and Dr. Robert Malenka unpack how the brain's reward circuitry works, centering on dopamine signaling from the ventral tegmental area to the nucleus accumbens. They explore why some substances and behaviors have high addictive liability, how the rate and amount of dopamine release drives craving, and how a single drug exposure can durably modify synapses. The conversation expands to serotonin and oxytocin, social interaction as a reward, and Malenka's mouse models of empathy. It closes with his research on MDMA, the serotonin-versus-dopamine basis of its prosocial versus addictive effects, and a cautious view on the therapeutic promise of psychedelics.
Big reveals
- Malenka notes alcohol use disorder runs in families and has a real genetic component, not just environmental.
- Malenka admits that 40 years after briefly smoking in Paris, returning to Paris still triggers cigarette cravings, illustrating cue-driven memory.
- Malenka reveals he was a very shy, insecure 20-year-old who lacked confidence in his ideas even through medical school.
- His lab showed a 'bystander' mouse develops pain just from spending an hour near a mouse in pain, likely via pheromone.
- Malenka argues, against some colleagues, that MDMA does carry addictive liability because it is an amphetamine derivative.
- Discloses he founded biotech Maplite Therapeutics (with Karl Deisseroth) and sits on MindMed's scientific advisory board.
- Malenka admits he had bad LSD trips in the '70s, one so dark it gave him a glimpse of suicidal hopelessness.
Things worth remembering
- Dopamine reward neurons live in the ventral tegmental area (VTA) and project mainly to the nucleus accumbens.
- Addictive liability correlates with both how much dopamine is released in the accumbens and how fast it is released.
- Route of administration matters: smoking or injecting a drug delivers it to the brain near-instantly, raising addictive risk.
- Researchers distinguish 'wanting' (reinforcing) from 'liking' (rewarding); a drug can be craved without being enjoyed.
- Prairie voles mate for life via oxytocin action in the nucleus accumbens, a classic pair-bonding finding.
- Mice can socially transfer pain relief (analgesia) just by a hurting mouse spending time with a morphine-treated one.
- MDMA reverses neurotransmitter transporters, causing neurons to 'spew out' dopamine and serotonin rather than reabsorb them.
- MDMA acts more strongly on serotonin than dopamine, roughly a 70/30 split, not 50/50.
- There are 16 different serotonin receptor subtypes distributed across the brain in complex ways.
- Kentucky allocated $42 million from the Purdue opioid settlement to study ibogaine.